Caiyun Mu

Prof. Dr. Caiyun Mu

College of Acumox and Tuina (College of Rehabilitation Medicine),, Anhui University of Chinese Medicine, Hefei, Anhui, China
orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 February 2026 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
ZWZijian Wang
Zijian Wang
RYRui Yu
Rui Yu
YZYing Zhou
Ying Zhou
JZJieying Zhang
Jieying Zhang
JYJiayi Yang
Jiayi Yang
MCMaowen Chen
Maowen Chen

Verified
Journal Article
Open access
PDF file
XYXu Tian You
Xu Tian You
RZRao Zhang
Rao Zhang
JHJiaxing Hu
Jiaxing Hu
JJJunnan Jiang
Junnan Jiang
LQLongjie Qiao
Longjie Qiao
Caiyun MuCaiyun Mu
Caiyun Mu
Epimedium is a traditional herb that has been investigated for its potential osteogenic and bone-regenerative effects, yet systematic analyses of its multi-component, multi-target mechanisms in bone metabolism and tissue engineering applications are limited. To address this knowledge gap, this narrative review systematically summarizes more than 20 bioactive constituents extracted from various parts of major medicinal Epimedium species. We elaborate on their pivotal roles in modulating osteogenic differentiation, suppressing osteoclastogenesis and bone resorption, regulating inflammatory responses, exerting antioxidant effects, promoting angiogenesis, demonstrating antitumor activity, exerting chondroprotective effects, and exhibiting antibacterial activity during bone defect repair. Furthermore, we highlight recent advancements and current trends in applying these bioactive constituents within the field of bone tissue engineering. Additionally, we compared the osteogenic and osteoprotective potentials of three metabolically related flavonoids (icariin, icaritin, and icariside II). Network pharmacology was utilized to elucidate their multi-target mechanisms in modulating bone metabolism, providing insights for future mechanistic studies. Despite the long-standing clinical use and extensive scientific investigation of Epimedium, this review identifies several challenges associated with its application in bone tissue engineering and offers constructive recommendations to overcome these limitations.